| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 256.13B | 250.24B | 208.33B | 187.30B | 165.45B | 141.22B |
| Gross Profit | 103.84B | 101.35B | 84.96B | 72.35B | 66.61B | 55.26B |
| EBITDA | 34.06B | 33.19B | 26.78B | 21.02B | 19.70B | 14.51B |
| Net Income | 17.23B | 16.35B | 9.81B | 8.31B | 9.11B | 5.37B |
Balance Sheet | ||||||
| Total Assets | 158.15B | 165.77B | 166.25B | 159.52B | 156.09B | 147.61B |
| Cash, Cash Equivalents and Short-Term Investments | 42.59B | 56.16B | 64.28B | 66.45B | 65.42B | 63.66B |
| Total Debt | 9.75B | 10.80B | 16.90B | 35.99B | 39.67B | 46.24B |
| Total Liabilities | 56.43B | 59.37B | 66.25B | 72.35B | 76.91B | 77.68B |
| Stockholders Equity | 101.72B | 106.40B | 100.00B | 87.17B | 79.17B | 69.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.17B | 27.61B | 14.70B | 13.47B | 13.82B |
| Operating Cash Flow | 0.00 | 17.00B | 29.18B | 16.22B | 16.41B | 18.06B |
| Investing Cash Flow | 0.00 | -8.10B | -5.32B | -2.13B | -2.49B | -8.61B |
| Financing Cash Flow | 0.00 | -16.77B | -27.15B | -13.69B | -12.99B | 6.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥35.57B | 9.47 | ― | 3.63% | -1.38% | 35.33% | |
73 Outperform | ¥2.44T | 17.78 | 15.67% | 1.94% | 8.60% | 10.04% | |
70 Outperform | ¥11.04B | 10.36 | ― | 2.70% | 14.99% | 40.36% | |
63 Neutral | ¥241.92B | 19.80 | ― | 2.18% | 8.08% | -27.93% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥3.52T | 49.78 | 12.54% | 0.48% | 3.70% | -1.69% | |
51 Neutral | ¥50.11B | 17.63 | ― | ― | 6.93% | ― |